• $5.99

Publisher Description

Introduction Recent National Institute for Health and Clinical Excellence (NICE) guidance for the diagnosis and management of attention deficit hyperactivity disorder (ADHD) in children, young people and adults, (1) has attracted media attention and reignited the debate surrounding treatment of the condition. Previous NICE guidance acknowledged the role of alternatives such as behaviour therapy, but recommended that use of medication should not be postponed if such provision was not available or was subject to delay. (2) The latest guidance appears to almost completely reverse the previously recommended approach, with behavioural therapies being promoted as a first-line treatment while medications such as methylphenidate (Ritalin) are recommended for use in severe cases only.

GENRE
Self-Development
RELEASED
2009
October 1
LANGUAGE
EN
English
LENGTH
18
Pages
PUBLISHER
Ten Alps Publishing
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
84.3
KB

More Books by Community Practitioner